title: Comparative plasma disposition kinetics of albendazole and its new benzimidazol prodrug in dog.
abstract: The comparative pharmacokinetic behavior of albendazole (ABZ) and its new benzimidazol prodrug [1-tert-butyloxycarbonyl-5-propylthio-1-H-benzimidazol-2ylcarbamate of methyl] (ABZBoc), following their oral administration (10mg/kg) to healthy dogs was explored. Blood samples were obtained serially over a 24h period after treatment, then the plasma was analyzed by high-performance liquid chromatography (HPLC) to search the albendazole metabolites (ABZSO and ABZSO2). However, the albendazole parent drug was not detectable at any time after both treatments (ABZ and ABZBoc). By albendazole metabolites (ABZSO and ABZSO2) were the analytes recovered in the plasma after oral administration of ABZ and ABZBoc. Furthermore, some amounts of ABZBoc were also available in the plasma samples treated with this new produg. The plasma profile of each analyte followed a similar pattern after both treatments, the active metabolite (ABZSO) was the major analyte recovered in plasma (between 1 and 24h post-treatment). The pharmacokinetic parameters of both groups were calculated (Cmax, Tmax, t1/2, AUC0-›∞), and analyzed using the Student's t-test, P<0.05. Thus,the pharmacokinetic analysis indicated four statistically significant changes in the pharmacokinetic parameters defined above of the albendazole metabolites (ABZSO, ABZSO2) between the group treated with albendazole (group A) and that treated with ABZBoc prodrug (group B). Hence, the levels of the various pharmacokinetics parameters were low in the group treated with prodrug, as well they did not reach equivalent concentrations to that of albendazole. These differences between albendazole and its new prodrug may be explained by the fact that ABZBoc prodrug was not effectively reduced in the intestine of dogs.
authors.affiliation: Laboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco. Electronic address: zineb.khalil@um5s.net.ma.
authors.forename: Z
authors.initials: Z
authors.lastname: Khalil
authors.affiliation: Physicochemical Service, Drugs Quality Control Laboratory, Division of Drugs and Pharmacy, Ministry of Health, Rabat, Morocco.
authors.forename: M
authors.initials: M
authors.lastname: El Karbane
authors.affiliation: Pharmacokinetics Research Team, Laboratory of Pharmacology and Toxicology, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
authors.forename: M E A
authors.initials: ME
authors.lastname: Faouzi
authors.affiliation: Laboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
authors.forename: M
authors.initials: M
authors.lastname: Ansar
authors.affiliation: Physicochemical Service, Drugs Quality Control Laboratory, Division of Drugs and Pharmacy, Ministry of Health, Rabat, Morocco.
authors.forename: M
authors.initials: M
authors.lastname: Azougagh
authors.affiliation: Laboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
authors.forename: J
authors.initials: J
authors.lastname: El Harti
authors.affiliation: Laboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
authors.forename: J
authors.initials: J
authors.lastname: Taoufik
mesh_terms: D015766:Albendazole / Q000031:analogs & derivatives / Q000493:pharmacokinetics*; D000818:Animals; D000871:Anthelmintics / Q000493:pharmacokinetics*; D004285:Dogs; D008297:Male; D011355:Prodrugs / Q000493:pharmacokinetics*
chemical_list: D000871:Anthelmintics; D011355:Prodrugs; D015766:Albendazole
keywords: Albendazole; Chiens; Dogs; HPLC; Metabolites; Métabolites; Pharmacocinétique; Pharmacokinetics; Prodrogue; Prodrug